OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: John Ringman

1 Projects | 1 Researchers | $299,451 Invested

2003

University of California, Los Angeles

John Ringman, MD

A Phase II, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of Three Doses of Curcumin versus Placebo in Patients with Mile to Moderate Alzheimer's Disease

  • Funding Amount: $299,451
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed